我国18个地市慢性阻塞性肺疾病诊疗能力现状调查

Status survey of the diagnosis and management ability of chronic obstructive pulmonary disease in eighty cities in China

目的了解我国基层不同级别医疗机构慢性阻塞性肺疾病(慢阻肺)诊治能力现状。方法对参加“幸福呼吸中国慢阻肺分级诊疗推广项目”的18个地市2017年慢阻肺治疗药物配备情况、肺功能仪配备情况和肺功能检查开展情况进行问卷调查。结果共有1386家不同级别医疗机构参加调查,三级医院吸入支气管扩张剂配备率100%,而一级医院吸入支气管扩张剂配备率35.5%,且均为短效吸入支气管扩张剂;三级医院中80%配备了简易肺功能仪,82.5%配备了大肺功能仪,而一级医院中仅13.8%配备了简易肺功能仪,一级医院开展用力肺活量检测率仅14.4%。结论我国不同级别医疗机构慢阻肺诊治能力差异巨大,基层医疗机构吸入药物配备率低下,肺功能仪配备率和肺功能检查的开展率低下,基层慢阻肺防治能力亟待提高。

Objective To learn about current status of the ability of diagnosis and management of chronic obstructive pulmonary disease(COPD)in different level hospitals.Method We conducted a questionnaire survey in different level hospitals participating in the Happy Breathing program in eighty cities about specific drugs for COPD,equipment and utilization of spirometry devices in 2017.Result 1386 different level hospitals participated in the survey.Inhaled bronchodilators were equipped in all tertiary hospitals,but were equipped in 35.5%of primary hospitals with short acting bronchodilators only.In the tertiary hospitals,80%of them had portable spirometry devices and 82.5%had more complicated lung function test equipment.While in the primary hospitals,only 13.8%of them had portable spirometry devices and only 14.4%of them can provided forced vital capacity measurement.Conclusion The ability of diagnosis and management of COPD differs significantly in different level hospitals.The equipment rate of inhaled drugs and spirometry devices,as well as utilization of lung function test was low.It is urgent to improve the ability of diagnosis and management of COPD in primary hospitals.